Edaravone Ameliorate Inflammation in Vitamin D 3 and High Fat Diet Induced Atherosclerosis in Rat via Alteration of Inflammatory Pathway and Gut Microbiota
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Lingjuan Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Second People's Hospital of Yunnan Province, Affiliated Hospital of Yunnan University, Kunming, China. Hauptthemen laut MEDLINE: Edaravone, Gastrointestinal Microbiome, Diet, High-Fat, Rats, Sprague-Dawley. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Yunnan Fundamental Research Projects (202201AT070105), Cardiovascular Ultrasound Innovation Team of Yunnan Province (202305AS350021), Yunnan Health Training Project of High Level Talents, H-2018030, H-2017017.
Abstract (Originalsprache)
Cardiovascular disease refers to a group of conditions that affect the heart and blood vessels, including coronary artery disease, heart failure, and stroke, among others. Edaravone (ED) inhibits oxidative stress and free radical damage, which are thought to contribute to the progression of various diseases. Thus, the purpose of the study is to examine the cardioprotective effect of ED against vitamin D 3 and high fat‐induced atherosclerosis in rats. In this study, Sprague Dawley (SD) rats were utilized. The rats were separated into several groups and fed a high‐fat diet along with vitamin D 3 to induce atherosclerosis. Various doses of ED were orally administered to the animals for 30 days. The administration of Edaravone effectively reduced the elevated body weight, as well as the excessive water and food consumption. The treated groups exhibited a decrease in glucose level, leptin, and apolipoprotein‐B. Administration of ED also modified the cholesterol parameters, coronary artery index, atherogenic index, and antioxidant parameters. It also reduced the elevated heart rate, systolic blood pressure (BP), mean BP, and diastolic BP. The group treated with ED exhibited a decrease in the level of inflammatory cytokines. The ED significantly ( p < 0.001) reduced the levels of MMP‐2, MMP‐3, and MMP‐9. Furthermore, it induced significant ( p < 0.001) adjustments in the abundance of Firmicutes, Bacteroidetes, Proteobacteria, Verrucomicrobia, and F/B ratio. Edaravone exhibited the cardio protection against HFD induced atherosclerosis in rats via alteration of gut microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Second People's Hospital of Yunnan Province, Affiliated Hospital of Yunnan University, Kunming, China.
Förderung
- Yunnan Fundamental Research Projects (202201AT070105)
- Cardiovascular Ultrasound Innovation Team of Yunnan Province (202305AS350021)
- Yunnan Health Training Project of High Level Talents, H-2018030, H-2017017
- Yunnan Provincial Department of Science and Technology Basic Research Program Kunming Medical University Joint Special Project
Zitieren
APA
Du, L., Wan, J., Yang, G., Ma, Z., Li, Z., & Li, G. (2024). Edaravone Ameliorate Inflammation in Vitamin D 3 and High Fat Diet Induced Atherosclerosis in Rat via Alteration of Inflammatory Pathway and Gut Microbiota. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70019
Vancouver
Du L, Wan J, Yang G, Ma Z, Li Z, Li G. Edaravone Ameliorate Inflammation in Vitamin D 3 and High Fat Diet Induced Atherosclerosis in Rat via Alteration of Inflammatory Pathway and Gut Microbiota. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70019
BibTeX
@article{Du2024,
author = {Du, Lingjuan and Wan, Jia and Yang, Guokai and Ma, Zhenhuan and Li, Zhaoxiang and Li, Guojian},
title = {Edaravone Ameliorate Inflammation in Vitamin D 3 and High Fat Diet Induced Atherosclerosis in Rat via Alteration of Inflammatory Pathway and Gut Microbiota},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.70019}
}
EUVIMED